Bridgeway Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,900
| Closed | -$612K | – | 1197 |
|
|
2024
Q3 | $612K | Sell |
1,900
-4,400
| -70% | -$1.44M | 0.01% | 813 |
|
|
2024
Q2 | $1.97M | Sell |
6,300
-24,850
| -80% | -$7.3M | 0.05% | 517 |
|
|
2024
Q1 | $8.86M | Sell |
31,150
-14,700
| -32% | -$4.3M | 0.18% | 162 |
|
|
2023
Q4 | $13.2M | Sell |
45,850
-5,300
| -10% | -$1.44M | 0.28% | 84 |
|
|
2023
Q3 | $13.7M | Sell |
51,150
-14,445
| -22% | -$3.6M | 0.33% | 50 |
|
|
2023
Q2 | $14.6M | Sell |
65,595
-10,800
| -14% | -$2.51M | 0.35% | 35 |
|
|
2023
Q1 | $18.5M | Buy |
76,395
+10,925
| +17% | +$2.68M | 0.49% | 10 |
|
|
2022
Q4 | $17.2M | Buy |
65,470
+9,395
| +17% | +$2.52M | 0.45% | 15 |
|
|
2022
Q3 | $12.6M | Sell |
56,075
-14,200
| -20% | -$3.44M | 0.34% | 41 |
|
|
2022
Q2 | $17.1M | Hold |
70,275
| – | – | 0.39% | 27 |
|
|
2022
Q1 | $17M | Sell |
70,275
-6,225
| -8% | -$1.43M | 0.33% | 43 |
|
|
2021
Q4 | $17.2M | Buy |
+76,500
| New | +$16.1M | 0.32% | 56 |
|
|
2020
Q4 | – | Sell |
-100,375
| Closed | -$25.5M | – | 1307 |
|
|
2020
Q3 | $25.5M | Sell |
100,375
-54,875
| -35% | -$13.6M | 0.59% | 27 |
|
|
2020
Q2 | $36.6M | Sell |
155,250
-83,700
| -35% | -$19.1M | 0.74% | 15 |
|
|
2020
Q1 | $48.4M | Sell |
238,950
-22,150
| -8% | -$4.84M | 1.11% | 6 |
|
|
2019
Q4 | $62.9M | Sell |
261,100
-70,250
| -21% | -$15.5M | 0.85% | 11 |
|
|
2019
Q3 | $64.1M | Hold |
331,350
| – | – | 0.89% | 20 |
|
|
2019
Q2 | $61.1M | Buy |
331,350
+13,500
| +4% | +$2.42M | 0.78% | 30 |
|
|
2019
Q1 | $60.4M | Buy |
317,850
+2,250
| +0.7% | +$430K | 0.75% | 32 |
|
|
2018
Q4 | $61.4M | Buy |
315,600
+3,100
| +1% | +$605K | 0.82% | 22 |
|
|
2018
Q3 | $64.8M | Buy |
312,500
+7,500
| +2% | +$1.48M | 0.63% | 41 |
|
|
2018
Q2 | $56.3M | Buy |
305,000
+157,500
| +107% | +$27.9M | 0.57% | 60 |
|
|
2018
Q1 | $25.1M | Hold |
147,500
| – | – | 0.27% | 101 |
|
|
2017
Q4 | $25.6M | Buy |
147,500
+2,500
| +2% | +$442K | 0.28% | 102 |
|
|
2017
Q3 | $27M | Buy |
+145,000
| New | +$25.7M | 0.31% | 99 |
|
|
2016
Q3 | – | Sell |
-1,600
| Closed | -$243K | – | 1429 |
|
|
2016
Q2 | $243K | Hold |
1,600
| – | – | ﹤0.01% | 1267 |
|
|
2016
Q1 | $240K | Hold |
1,600
| – | – | ﹤0.01% | 1267 |
|
|
2015
Q4 | $260K | Hold |
1,600
| – | – | ﹤0.01% | 1241 |
|
|
2015
Q3 | $221K | Sell |
1,600
-20,500
| -93% | -$3.23M | ﹤0.01% | 1286 |
|
|
2015
Q2 | $3.39M | Sell |
22,100
-98,400
| -82% | -$15.8M | 0.07% | 326 |
|
|
2015
Q1 | $19.3M | Hold |
120,500
| – | – | 0.4% | 62 |
|
|
2014
Q4 | $19.2M | Buy |
+120,500
| New | +$18.8M | 0.44% | 50 |
|
|
2013
Q3 | – | Sell |
-53,800
| Closed | -$5.31M | – | 1422 |
|
|
2013
Q2 | $5.31M | Buy |
+53,800
| New | +$5.58M | 0.21% | 78 |
|
Other funds holding AMGN
Bridgeway Capital Management's AMGN Position: Q4 2024 in Review
Bridgeway Capital Management sold out of Amgen (AMGN) in Q4 2024, closing a stake of 1,900 shares — an estimated $612K sold.
Bridgeway Capital Management first reported a position in AMGN in Q2 2013 and held it in 33 quarters. The position peaked at $64.8M in Q3 2018. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.
- Bridgeway Capital Management reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
- Bridgeway Capital Management sold 1,900 Amgen shares in Q4 2024, an estimated $612K.
- Bridgeway Capital Management first reported a position in Amgen in Q2 2013 and held it in 33 quarters.
- Bridgeway Capital Management's Amgen position peaked at $64.8M in Q3 2018.
- 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.
Based on Bridgeway Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.